(Q82345634)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21056746%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

The GH/IGF-1 axis in growth and development: new insights derived from animal models (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21056746%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21056746%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Dara Cannata

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21056746%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Yvonne Fierz

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21056746%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Derek LeRoith

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21056746%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21056746%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

published in

Advances in pediatrics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21056746%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21056746%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21056746%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

331-351

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21056746%20AND%20SRC:MED&resulttype=core&format=json

Insulin-like growth factors and the basis of growth

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Interactions between GH, IGF-I, glucocorticoids, and thyroid hormones during skeletal growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Circulating levels of IGF-1 directly regulate bone growth and density

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Control of growth hormone synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Understanding the multifactorial control of growth hormone release by somatotropes: lessons from comparative endocrinology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Characterization of rat hypothalamic growth hormone-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Mouse serum growth hormone (GH) binding protein has GH receptor extracellular and substituted transmembrane domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Serum and liver cytosolic growth-hormone-binding proteins are antigenically identical with liver membrane 'receptor' types 1 and 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Release of growth hormone binding protein from IM-9 lymphocytes by endopeptidase is dependent on sulfhydryl group inactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

The circulating growth hormone (GH)-binding protein complex: a major constituent of plasma GH in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Transgenic rabbits overexpressing growth hormone develop acromegaly and diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

The somatomedin hypothesis: 2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Insulin-like growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Insulin-like growth factor receptors and binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Modifications of insulin-like growth factor binding proteins and their role in controlling IGF actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Functional analysis of the rat insulin-like growth factor I gene and identification of an IGF-I gene promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Growth hormone rapidly activates insulin-like growth factor I gene transcription in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Regulation of insulin-like growth factor I gene expression by growth hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Insulinlike growth factor I regulation of growth hormone gene transcription in primary rat pituitary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Endocrine regulation of the growth plate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

The role of the resting zone in growth plate chondrogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Effects of estrogen on growth plate senescence and epiphyseal fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Skeletal growth and peak bone strength.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

7 January 2021

Growth hormone and bone

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

The effect of hypophysectomy and growth hormone on S35 fixation in cartilage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Somatomedin: Proposed Designation for Sulphation Factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Evidence that somatomedin is synthesized by multiple tissues in the fetus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Growth hormone stimulates longitudinal bone growth directly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

A dual effector theory of growth-hormone action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Growth hormone induces multiplication of the slowly cycling germinal cells of the rat tibial growth plate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Cellular patterns of insulin-like growth factor system gene expression in murine chondrogenesis and osteogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Igf1 promotes longitudinal bone growth by insulin-like actions augmenting chondrocyte hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Insulin-like growth factor-I is essential for embryonic bone development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Insulin-like growth factor-I and fibroblast growth factor, but not growth hormone, affect growth plate chondrocyte proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

The somatomedin hypothesis 2007: 50 years later

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Cloning of two novel growth hormone transcripts expressed in human placenta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Growth hormone receptor binding protein in rat anterior pituitary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

The effect of free fatty acids on growth hormone (GH)-releasing hormone-mediated GH secretion in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Growth hormone deficiency presenting under age 2 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

How growth hormone controls growth, obesity and sexual dimorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Growth hormone (GH), GH receptor, and signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

The growth hormone cascade and its role in mammalian growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

The prolactin/growth hormone receptor family: structure/function relationships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Role of the growth hormone (GH) receptor transmembrane domain in receptor predimerization and GH-induced activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Characterization of distinct Stat5b binding sites that mediate growth hormone-stimulated IGF-I gene transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Defects in growth hormone receptor signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Growth hormone insensitivity associated with a STAT5b mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Insulin signalling and the regulation of glucose and lipid metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Inherited Ateliotic Dwarfism in Mice: Characteristics of the mutation, little, on Chromosome 6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

New mouse dw allele: genetic location and effects on lifespan and growth hormone levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

HISTOLOGY OF THE ANTERIOR HYPOPHYSIS, THYROID AND GONADS OF TWO TYPES OF DWARF MICE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

The response of two types of dwarf mice to growth hormone, thyrotropin, and thyroxine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Stimulation of growth in the little mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Effects of Prolactin (PRL) on Pituitary and Testicular Function in Mice with Hereditary PRL Deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Dwarf mice and the ageing process.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Molecular basis of the little mouse phenotype and implications for cell type-specific growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Etiology of Growth Hormone Deficiency in Little, Ames, and Snell Dwarf Mice*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Is the Laron mouse an accurate model of Laron syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

High incidence of perinatal insult in children with idiopathic hypopituitarism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Congenital idiopathic growth hormone deficiency associated with prenatal and early postnatal growth failure. The International Board of the Kabi Pharmacia International Growth Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Auxological, clinical and neuroradiological findings in infants with early onset growth hormone deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Linear growth characteristics of congenitally GH-deficient infants from birth to one year of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Laron syndrome: typical and atypical forms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Absence of the plasma growth hormone-binding protein in Laron-type dwarfism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Spectrum of growth hormone receptor mutations and associated haplotypes in Laron syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

The little women of Loja--growth hormone-receptor deficiency in an inbred population of southern Ecuador

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

IGF-I treatment of adult patients with Laron syndrome: preliminary results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Bone mineral, histomorphometry, and body composition in adults with growth hormone receptor deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Growth patterns and body composition of transgenic mice expressing mutated bovine somatotropin genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Body composition, bone mass and microstructural analysis in GH-transgenic mice reveals that skeletal changes are specific to bone compartment and gender.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Sexual dimorphism in cortical bone size and strength but not density is determined by independent and time-specific actions of sex steroids and IGF-1: evidence from pubertal mouse models.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Medical progress: Acromegaly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Pituitary tumors in childhood: update of diagnosis, treatment and molecular genetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Alterations in body composition in acromegaly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Fracture risk is decreased in acromegaly--a potential beneficial effect of growth hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Effects of short-term insulin-like growth factor-I or growth hormone treatment on bone turnover, renal phosphate reabsorption and 1,25 dihydroxyvitamin D3 production in healthy man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Role of insulin-like growth factors in embryonic and postnatal growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Impaired skeletal growth in mice with haploinsufficiency of IGF-I: genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Mutation at cleavage site of insulin-like growth factor receptor in a short-stature child born with intrauterine growth retardation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Homozygous and heterozygous expression of a novel mutation of the acid-labile subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Differential expression of alternative 5' untranslated regions in mRNAs encoding rat insulin-like growth factor I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Distribution and regulation of rat insulin-like growth factor I messenger ribonucleic acids encoding alternative carboxyterminal E-peptides: evidence for differential processing and regulation in liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Tissue distribution of insulin-like growth factor I and II messenger ribonucleic acid in the adult rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Normal growth and development in the absence of hepatic insulin-like growth factor I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

The hormonal action of IGF1 in postnatal mouse growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

Elevated levels of insulin-like growth factor (IGF)-I in serum rescue the severe growth retardation of IGF-I null mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2010.09.003

10.1016/J.YAPD.2010.09.003

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21056746%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference